Text
Regional for Basic Emergency Obstetrict and Neonatal Care (BEONC): an Disparity Of Drug Availability Indonesian National Study in 2011
As an important component to support the implementation of the Basic Emergency Obstetric and Neonatal Care (BEONC)the drugs should be available in the district/city pharmacy (IFK) in entire region in Indonesia. However, availability disparity occurred. Therefore, it is necessary to describe the disparity on the availability drugs in Indonesia.
A cross-sectional study was conducted in August-October 2011, which covered all IFK districts / municipalities in 33 provinces of Indonesia. The location comprised regional: Sumatra, Java and Bali, Nusa Tenggara, Kalimantan, Sulawesi, Maluku, and Papua. BEONC essential medicines were divided into two classifications: (1) very very important, and (2) very important.
In January 2012, out of 497 districts / cities 316 (64%) were available for this analysis. There were disparities on availability BEONC classified as very very important as well as very important drugs. Among the very important BEONC essential drugs, Dextrose infusion and Ergomterin / methiler-gometrin maleate injection, and injection Oxytosin available in all regions except in the Maluku. Anti-tetanus serum (ATS), furosemide injection, furosemide injection, Magnesium sulfate, and Procaine Penicillin were available in all regions. The important BEONC essential drugs, except Bicarbonas in Papua, all essential drugs BEONC less available in all regions. The most available was A2 infusion fluid, Cedilanide injection, sodium bicarbonate injection, and pethidine injection. It seemed that Nusa Tenggara region had relatively better BEONC drug stock as compared to other regions.
There was significantly disparity on availability of very important essential BEONC drugs in all regions in Indonesia. Therefore it is necessary to solve the disparity problems of BEONC drugs. (Health Science Indones 2012;2:xx-xx)
No other version available